Top compounds associated with response to MAML2


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC -0.0062 0.9
mRNA VX-680 GDSC1000 pan-cancer AAC -0.0064 0.9
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.0041 0.9
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA thalidomide CTRPv2 pan-cancer AAC 0.0062 0.9
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.0049 0.9
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.0055 0.9
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.0037 0.9
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.0042 0.9
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC -0.0052 0.9
Download CSV